BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33650193)

  • 1. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion.
    Zhou Y; Chen Y; Zhang X; Xu Q; Wu Z; Cao X; Shao M; Shu Y; Lv T; Lu C; Xie M; Wen T; Yang J; Shi Y; Bu H
    Hepatology; 2021 Aug; 74(2):797-815. PubMed ID: 33650193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling.
    Shu Y; Xu Q; Xu Y; Tao Q; Shao M; Cao X; Chen Y; Wu Z; Chen M; Zhou Y; Zhou P; Shi Y; Bu H
    Cell Death Dis; 2021 Oct; 12(11):966. PubMed ID: 34667161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt/β-catenin/autophagy axis.
    Gong W; Luo C; Peng F; Xiao J; Zeng Y; Yin B; Chen X; Li S; He X; Liu Y; Cao H; Xu J; Long H
    Clin Sci (Lond); 2021 Aug; 135(15):1873-1895. PubMed ID: 34318888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.
    Wang C; Yang W; Yan HX; Luo T; Zhang J; Tang L; Wu FQ; Zhang HL; Yu LX; Zheng LY; Li YQ; Dong W; He YQ; Liu Q; Zou SS; Lin Y; Hu L; Li Z; Wu MC; Wang HY
    Hepatology; 2012 Jan; 55(1):108-20. PubMed ID: 21932402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
    Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
    Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor Progression.
    Di-Luoffo M; Pirenne S; Saandi T; Loriot A; Gérard C; Dauguet N; Manzano-Núñez F; Alves Souza Carvalhais N; Lamoline F; Cordi S; Konobrocka K; De Greef V; Komuta M; Halder G; Jacquemin P; Lemaigre FP
    Hepatology; 2021 Sep; 74(3):1445-1460. PubMed ID: 33768568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brg1 is required for stem cell maintenance in the murine intestinal epithelium in a tissue-specific manner.
    Holik AZ; Krzystyniak J; Young M; Richardson K; Jardé T; Chambon P; Shorning BY; Clarke AR
    Stem Cells; 2013 Nov; 31(11):2457-66. PubMed ID: 23922304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway.
    Shen J; Zhou Y; Zhang X; Peng W; Peng C; Zhou Q; Li C; Wen T; Shi Y
    Aging (Albany NY); 2019 Nov; 11(21):9280-9294. PubMed ID: 31689237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
    Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
    Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β/YB-1/Atg7 axis promotes the proliferation of hepatic progenitor cells and liver fibrogenesis.
    Guo Y; Zhu J; Xu X; Shen B; Shen Z; Li B; Li F; Gu T; Cai X; Dong H; Lu L
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166290. PubMed ID: 34662704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Intrahepatic Cholangiocarcinoma with Focal Rhabdoid Features and SMARCA4-Deficiency.
    Minato H; Yoshikawa A; Katayanagi K; Kurumaya H; Kato K; Kitamura H
    Int J Surg Pathol; 2022 Aug; 30(5):581-585. PubMed ID: 34955041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach.
    Ahn KS; O'Brien D; Kang YN; Mounajjed T; Kim YH; Kim TS; Kocher JA; Allotey LK; Borad MJ; Roberts LR; Kang KJ
    Hepatol Int; 2019 Jul; 13(4):490-500. PubMed ID: 31214875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
    Ge M; Chen H; Zhu Q; Cai J; Chen C; Yuan D; Jin Y; Yao W; Hei Z
    J Cell Mol Med; 2017 Dec; 21(12):3693-3704. PubMed ID: 28749008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
    Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
    Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRG1 regulates endothelial-derived IL-33 to promote ischemia-reperfusion induced renal injury and fibrosis in mice.
    Liu L; Mao L; Wu X; Wu T; Liu W; Yang Y; Zhang T; Xu Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2551-2561. PubMed ID: 31228616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
    Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
    Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
    Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.